Dec 1, 2020
CaaMTech, Inc., announced today that the company has entered into a collaborative research agreement with the Leibniz Institute for Natural Product Research and Infection Biology to research psychedelic mushroom compositions. The Leibniz Institute for Natural Product Research and Infection Biology (also known as the Hans Knöll Institute [HKI] after its founder) is located in Jena, Germany. Famed mycologist Prof. Dr. Dirk Hoffmeister, head of the Research Group Pharmaceutical Microbiology, will lead the research on behalf of HKI.
The collaborative research aims to fill several gaps in the scientific understanding of the chemical composition of psychedelic psilocybin-containing mushrooms, colloquially known as "magic mushrooms." Magic mushrooms (and their most well known psychedelic compound, psilocybin) have undergone a wave of new research in the past several years. More recently, magic mushrooms have been decriminalized in several US jurisdictions and Oregon voters overwhelmingly moved to legalize psychotherapy utilizing these fungi in a November ballot measure.
"Psilocybin is just one of many tryptamines found in magic mushrooms and probably not the one with the most potential or the most important effects," said Dr. Andrew Chadeayne, CEO of CaaMTech. "Understanding the chemical composition of magic mushrooms allows us to quantifiably distinguish their effects from pure psilocybin and harness the advantages."
The research, conducted by Dr. Hoffmeister's team at HKI will, among other work, examine the chemical variability within and between magic mushroom strains.
"Metabolic profiling of these fungi is an exciting endeavor," said Dr. Hoffmeister. "A more global view on their metabolic diversity has surprisingly not been undertaken yet, but is needed to help us understand their effects more profoundly. From an academic perspective, it may also tell us why nature has evolved these compounds."
About CaaMTech
CaaMTech is the foremost drug discovery and lead optimization company focused on engineering psychedelic drugs that meet the standards of modern medicine. CaaMTech is improving the health and happiness of humankind by creating and optimizing psychedelic compounds and formulations through rigorous science and continuous innovation.
Media Contact
Davis Wuolle
[email protected]
+1.510.747.9001
The NSW regulator said questions remained about the casino’s progress in improving its governance, leadership and culture.
There is no ‘spare adult’ to play backstop in single-parent households – and Australia has 1.2 million of them. We haven’t adjusted for this reality.
Aurum Resources has tabled a stunning 1.3m hit grading 155g/t gold at its 3.22Moz Boundiali project in Côte d’Ivoire, West Africa, ahead of a key resource update.
Zenith Minerals has hit gold in every one of the first holes drilled in a 600-metre gap at its Dulcie gold project in WA. Assays from another 25 holes are pending.
Kuniko Ltd has wrapped up phase two drilling at its NSW gold-silver project, with assays pending and a resource update targeted for Q4 in the hot Lachlan Fold Belt.
The Australian sharemarket fell to a three-month low as oil prices moved higher, before an expected rise in interest rates next week.
Australia’s biggest fast food giants are leaning hard into the trend of brightly coloured, wacky-flavoured soft drinks.
A Brazilian-Latvian influencer who has spoken out about racism is the inadvertent face of T-shirts for the conservative news and opinion outlet.
A romantic relationship with a colleague might cause genuine problems but if you’re just inviting them to a barbecue, there is room to manoeuvre.
The Brownlow medallist is likely to get less than the $3 million he paid for a building in the Melbourne suburb of Abbotsford.
We shouldn’t be aiming for more children, but it might be a side effect of focusing on the right thing as we face an ageing population.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.